DEFINIUM THERAPEUTICS, INC.
NASDAQ: DFTX (Definium Therapeutics, Inc.)
Kemas kini terakhir: 16 jam lalu37.40
-0.20 (-0.53%)
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Definium Therapeutics, Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.88 |
|
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BARROW ROBERT | - | 36.17 | -31,550 | -1,141,164 |
| KARLIN DANIEL | - | 36.17 | -10,853 | -392,553 |
| ROBERTS BRANDI | - | 36.17 | -3,377 | -122,146 |
| SULLIVAN MARK | - | 36.17 | -14,051 | -508,225 |
| WILEY MATTHEW T. | - | 36.17 | -3,097 | -112,018 |
| Jumlah Keseluruhan Kuantiti Bersih | -62,928 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,276,106 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 36.17 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ROBERTS BRANDI | Pegawai | 25 Sep 2026 | Jual automatik (-) | 3,377 | 36.17 | 122,146 |
| SULLIVAN MARK | Pegawai | 25 Sep 2026 | Jual automatik (-) | 14,051 | 36.17 | 508,225 |
| WILEY MATTHEW T. | Pegawai | 25 Sep 2026 | Jual automatik (-) | 3,097 | 36.17 | 112,018 |
| BARROW ROBERT | Pegawai | 25 Sep 2026 | Jual automatik (-) | 31,550 | 36.17 | 1,141,164 |
| KARLIN DANIEL | Pegawai | 25 Sep 2026 | Jual automatik (-) | 10,853 | 36.17 | 392,553 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |